Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Windtree Therapeutics Inc (WINT)  
$0.16 0.00 (0.00%) as of 4:30 Thu 2/23


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 16,920,000
Market Cap: 2.77(M)
Last Volume: 25,688,722 Avg Vol: 24,231,703
52 Week Range: $0.164 - $0.164
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:
    NASDAQ BIOTECHNOLOGY     NASDAQ COMPOSITE
    NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Windtree Therapeutics is a clinical-stage, biopharmaceutical company focused on the development of therapeutics to address unmet medical needs in acute care markets. Co.'s primary product candidate, istaroxime, is a dual-acting agent being developed to improve cardiac function in patients with acute heart failure. In addition, Co. cardiovascular drug product candidates include rostafuroxin, for the treatment of hypertension in patients with a specific genetic profile. Co.'s pulmonary product candidate portfolio consists of a KL4 surfactant platform to address a range of serious respiratory conditions in children and adults.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 2,500 24,812
Total Buy Value $0 $0 $2,250 $15,204
Total People Bought 0 0 1 2
Total Buy Transactions 0 0 1 8
Total Shares Sold 0 0 0 0
Total Sell Value $0 $0 $0 $0
Total People Sold 0 0 0 0
Total Sell Transactions 0 0 0 0
End Date 2024-03-03 2023-12-01 2023-06-02 2022-06-02

   
Records found: 619
  Page 17 of 25  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Cole Kathy Senior VP, Human Resources   •       –      –    2007-12-31 4 A $2.15 $1,939 D/D 902 5,026     -
   Cooper John G Exec. VP, CFO   •       –      –    2007-12-31 4 A $2.15 $1,939 D/D 902 52,394     -
   Lopez David L Executive VP & Legal Counsel   •       –      –    2007-12-31 4 A $2.15 $1,875 D/D 872 44,431     -
   Capetola Robert J President/CEO   •       •      –    2007-12-31 4 A $2.15 $1,939 D/D 902 297,873     -
   Rosenthale Marvin E Director   –       •      –    2007-11-20 4 B $2.40 $36,000 I/I 15,000 65,000 2.1     -
   Lopez David L Executive VP & Legal Counsel   •       –      –    2007-11-19 4 B $2.42 $19,239 D/D 7,900 43,559 2.74     -
   Capetola Robert J President/CEO   •       •      –    2007-11-16 4 B $2.54 $127,000 D/D 50,000 296,944 2.81     -
   Amick W Thomas Director   –       •      –    2007-11-15 4 B $2.32 $23,200 D/D 10,000 20,000 2.39     -
   Cooper John G Exec. VP, CFO   •       –      –    2007-09-30 4 A $2.50 $1,938 D/D 775 51,492     -
   Segal Robert-Md Sr VP, Chief Medical Officer   •       –      –    2007-09-30 4 A $2.50 $1,940 D/D 776 14,491     -
   Miller Thomas F SVP, Commercial..& Corp. Dev.   •       –      –    2007-09-30 4 A $2.50 $1,938 D/D 775 13,927     -
   Cole Kathy Senior VP, Human Resources   •       –      –    2007-09-30 4 A $2.50 $1,938 D/D 775 4,124     -
   Lopez David L Executive VP & Legal Counsel   •       –      –    2007-09-30 4 A $2.50 $1,875 D/D 750 35,659     -
   Capetola Robert J President/CEO   •       •      –    2007-09-30 4 A $2.50 $1,938 D/D 775 246,944     -
   Capetola Robert J President/CEO   •       •      –    2007-08-03 4 B $2.15 $53,630 D/D 25,000 246,169 2.81     -
   Cooper John G Exec. VP, CFO   •       –      –    2007-06-30 4 A $2.83 $1,936 D/D 684 50,717     -
   Segal Robert-Md Sr VP, Chief Medical Officer   •       –      –    2007-06-30 4 A $2.83 $1,936 D/D 684 13,715     -
   Miller Thomas F SVP, Commercial..& Corp. Dev.   •       –      –    2007-06-30 4 A $2.83 $1,939 D/D 685 13,152     -
   Cole Kathy Senior VP, Human Resources   •       –      –    2007-06-30 4 A $2.83 $1,936 D/D 684 3,349     -
   Lopez David L Executive VP & Legal Counsel   •       –      –    2007-06-30 4 A $2.83 $1,876 D/D 663 34,909     -
   Capetola Robert J President/CEO   •       •      –    2007-06-30 4 A $2.83 $1,936 D/D 684 221,169     -
   Segal Robert-Md Sr VP, Chief Medical Officer   •       –      –    2007-03-31 4 A $2.31 $1,876 D/D 812 13,005     -
   Miller Thomas F SVP, Commercial..& Corp. Dev.   •       –      –    2007-03-31 4 A $2.31 $1,873 D/D 811 12,440     -
   Cole Kathy Senior VP, Human Resources   •       –      –    2007-03-31 4 A $2.31 $1,876 D/D 812 2,638     -
   Capetola Robert J President/CEO   •       •      –    2007-03-31 4 A $2.31 $1,876 D/D 812 220,485     -
  619 Records found
  Previous  10  11  12  13  14  15  16  17  18  19  Next   
  Page 17 of 25
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us